| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $756.0M | $681.9M | $660.7M |
| YoY Revenue Growth % | +10.9% | +3.2% | — |
| Gross Profit | $498.1M | $441.8M | — |
| Gross Margin % | 65.9% | 64.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $25.0M | $35.6M | $21.1M |
| Operating Margin % | 3.3% | 5.2% | 3.2% |
| Net Income (GAAP) | $15.4M | $30.0M | $14.0M |
| EBITDA (Normalized) | $49.2M | $64.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $178.2M | $135.6M | $124.3M |
| Capital Expenditures (CapEx) | $30.3M | $35.7M | — |
| Free Cash Flow (FCF) | $147.9M | $99.9M | $124.3M |
| FCF Margin % | 19.6% | 14.7% | 18.8% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $203.1M | $142.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $171.9M | $93.3M | — |